← Leaderboards
Wells B Lariviere
University Of Colorado Denver
$150,312
Attributed
$150,312
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51K · FY2018–21$100K$75K$50K$25K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$150,312 · 1
By mechanism
F31$150,312 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Paco S Herson$11,691,083
- Charles Anthony Dinarello$9,696,715
- Kevin J. Staley$35,882,339
- Robert Turner Schooley$73,100,957
- Andrew P Fontenot$19,585,312
Others in their field
Other Emerging Leaders on “Acetyltransferase”
- Carla Nasca · New York University School Of Medicine$5,293,907
- Srikanth Singamsetty · Phoenix Nest, Inc.$5,047,122
- Laura Banaszynski · Ut Southwestern Medical Center$3,611,367
- George Burslem · University Of Pennsylvania$3,117,957
- Misty Kuhn · San Francisco State University$2,484,703
- Sheena D'arcy · University Of Texas Dallas$2,474,920
Research focus
AcetyltransferaseAcute Lung InjuryAdult Respiratory Distress SyndromeAcuteAttenuatedBaseBeta-GlucuronidaseBindingBiologyAnalogCalorimetryCell NucleusCell SurfaceCell TypeCharacteristicsChronicCleaved CellCollagenColoradoComplement Factor BDepositionBleomycinEpigenetic ProcessExperimental Study
Grant awards (4)
Nuclear Heparan Sulfate Mediates Fibroblast Activation in Indiopathic Pulmonary Fibrosis$51,036
F31 · FY2021 · HL · contact PI
Nuclear Heparan Sulfate Mediates Fibroblast Activation in Indiopathic Pulmonary Fibrosis$33,867
F31 · FY2020 · HL · contact PI
Nuclear Heparan Sulfate Mediates Fibroblast Activation in Indiopathic Pulmonary Fibrosis$33,363
F31 · FY2019 · HL · contact PI
Nuclear Heparan Sulfate Mediates Fibroblast Activation in Indiopathic Pulmonary Fibrosis$32,046
F31 · FY2018 · HL · contact PI